Abstract
Chronic renal failure (CRF) is a threat to global health in general and for developing countries in particular. Globally CRF is the 12th highest cause of death. CRF is a progressive loss in renal function taking place over a period of months or years. This initially manifests only as a biochemical abnormality. CRF is considered when glomerular filtration rate (GFR) falls below 30ml/min. The conventional approach of management includes dialysis and renal transplantation, which are not affordable. Therefore, exploration of a safe and alternative therapy is needed. In Ayurveda, the disease can be consider as complication arising from various urinary disorders. A hampering of the function of basti, i.e. urine formation, results in the accumulation of several noxious products in circulation which need excreted management is aimed at eliminating these toxins, to protect the accessible renal cells rejuvenate the quiet cells. In Ayurveda several drugs are used as nephroprotective and this group of drug acts as good non- specific cytoprotectives. In this regard Ayurveda provides leads through its holistic line of management by in co-operative dietary and lifestyle invention and bio-balancing effects of Ayurvedic drugs.
References
2. Agniveshakrita Trikamji Acharya;Charak Samhita;Sutrasthan; Shadvirechashratiya Adhyay Ch.4,shlok34,35. Varanasi:Chaukhamba Surbharati Prakashan;2005 Re-print,pg-90.
3. Davidson S.Davidsons principles and practice of medicine.20th ed. Philadelphia : churchil Livingstone Elsevier publication;2006. P.485
4. El-atat fa, stas Sn, mc farlane sl, sowers JR, The relationship between Hyperinsulinemia, hypertension and progressive renal disease. J am soc nephrol 2004; 15:2816-27
5. Shah H. incidence of micro-albuminuria in tobacco cheweres. Indian J clin biochem 2005;20:189-91
6. Iliescu EA, Yeates KE,Holland DC. Quality of sleep in patients with chronic kidney, Nephrol Dial Transplant 2004;19:95-9
7. Hebert LA, Wilmer WA, falkenhain ME, Ladson – Wofford SE, Nahman NS Jr, Rovin BH.Renoprotection: one or many therapies? Kidney Int s
8. Taal mw, Brenner Bm. Renoprotective benefits of RAS Inhibition: from ACEI to angiotensin II antagonists. Kidney Int 2000;57:1803-17
9. Zoja c. morigi m, Remuzzi G. proteinuria and phenotypic change of proximal tubular cells. J AM Soc nephrol 2003;14:536-41
10. Kim Ah.Macleod’s clinical examination. IN Graham D,editor 11th edition. Toronto: Elsevier Churchill Livingstone publication;2005 p.194
11. V.M.Gogte: Ayurvedic Pharmcalogy and therapeutic uses of medicinal plants: Bharatia vidya Bhawan’s swami Prakash nanda Ayurveda research centre,oct -2000 Eng. Edition Bharatiya vidya bhawan ,Mumbai.
12. Prof.K.C.Chunekar: Dravyagunvidnyanam: 2nd edition 2005, Chaukhamba orientalia, Varanasi.
13. Emil A. Tanghao:Smith’s General Urology:William J.C.Amend:chronic renal failure and dialysis;17th edition;chapter no.34;pg no.535
14. Prof. Vaidya K.S.Dhiman; CCRAS; Medicinal plants research (contd.) Vol-II & III;Ministry of Ayush,Government of India,New Delhi
I declare (on behalf of me and my co-authors) that the submitted manuscript titled has not previously been published and is not currently being considered elsewhere for publication in another journal and that I am (we are) the sole owner(s) of the manuscript thereof and of all rights, title, and interest therein. All agreed to the terms and conditions, Privacy Policy, which is declared on Journal Website http://www.ayurlog.com and online filled (uploaded) form